At its second attempt, Rocket Pharma has won FDA approval for its gene therapy for severe leukocyte adhesion deficiency type I (LAD-I), a rare and life-threatening immune disorder that leaves patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results